Health
The reasons why regulators aren’t greenlighting existing medical treatments that show promise for coronavirus – ABC News
There are existing medications and treatments that seem to show some promise and have already been evaluated for safety. So why not just greenlight these? What are the potential downsides to this approach?
Aspirin was originally developed as a painkiller, but now many people take it every day to prevent heart disease.
Scientists are taking a similar approach in their hunt to find medications to treat coronavirus: looking for drugs already approved for use in managing certain conditions that show promise in treating COVID-19.
Using a repurposed drug is the easiest path to take when looking for a new medical treatment, explains infectious diseases expert Sharon Lewin, director of the Peter Doherty…
-
General20 hours agoRestaurants on the brink as business failures plateau
-
General17 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General9 hours agoThree maps that show the scale of the NSW flood disaster
-
General18 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’